Palatin Technologies
PTN
#10515
Rank
C$28.89 M
Marketcap
C$16.24
Share price
9.37%
Change (1 day)
13,087.74%
Change (1 year)

Palatin Technologies (PTN) - Total debt

Total debt on the balance sheet as of September 2025 : C$0.18 Million

According to Palatin Technologies's latest financial reports the company's total debt is C$0.18 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Palatin Technologies - Total debt on balance sheet (from 1997 to 2025)

Total debt by year

Year Total debt Change
2025-06-30C$0.22 M-72.39%
2024-06-30C$0.8 M-41.96%
2023-06-30C$1.39 M-6.38%
2022-06-30C$1.48 M-4.29%
2021-06-30C$1.55 M-9.7%
2020-06-30C$1.71 M294.4%
2019-06-30C$0.43 M-94.72%
2018-06-30C$8.26 M-54.97%
2017-06-30C$18.34 M-27.49%
2016-06-30C$25.29 M105.87%
2015-06-30C$12.28 M
2014-06-30N/A-100%
2013-06-30C$0.02 M-51.27%
2012-06-30C$0.04 M-42.2%
2011-06-30C$0.07 M106.75%
2010-06-30C$0.03 M-74.28%
2009-06-30C$0.13 M-64.34%
2008-06-30C$0.39 M-24.84%
2007-06-30C$0.52 M48.56%
2006-06-30C$0.35 M836.2%
2005-06-30C$0.03 M-55.79%
2004-06-30C$0.08 M-76.19%
2003-06-30C$0.35 M
2001-06-30C$0.04 M
1999-06-30C$2.94 M122.36%
1998-06-30C$1.32 M-46.72%
1997-06-30C$2.48 M-44%
1996-06-30C$4.43 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
C$78.04 B 41,516,442.59%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$48.14 B 25,608,827.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$0.57 B 306,591.03%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
C$0.25 M 36.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$0.64 B 341,153.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
C$0.87 B 463,303.95%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
C$0.29 B 157,144.46%๐Ÿ‡บ๐Ÿ‡ธ USA